PDCD1 and cancer: Several strategies have been explored of which therapeutic cancer vaccination [58–63], adoptive T-cell transfer [64], [65] and more recently blockade of inhibitory receptors such as programmed cell death-1 (PD-1) and cytotoxic T lymphocyte-associated antigen-4 (CTLA-4) [66–72] have shown promising results.